Episode 184: PREMIUM - Two more blood pressure/chlolesterol changing drugs that are a flop
Submitted by JPM on Tue, 2012-11-20 16:13.
In episode 184, James and Mike don their PREMIUM critical appraisal hats yet again to report the results of important recent studies that examine the impact two “new” drugs, aliskiren and dalcetrapib, have on clinically important outcomes.